Bayesian Capital Management’s Nice NICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,465
Closed -$1.95M 977
2024
Q1
$1.95M Buy
7,465
+4,600
+161% +$1.04M 0.19% 159
2023
Q4
$572K Buy
+2,865
New +$515K 0.06% 353
2023
Q3
Sell
-4,405
Closed -$910K 884
2023
Q2
$910K Buy
+4,405
New +$909K 0.1% 278
2023
Q1
Sell
-6,808
Closed -$1.31M 993
2022
Q4
$1.31M Buy
+6,808
New +$1.31M 0.19% 127
2021
Q2
Sell
-1,100
Closed -$240K 567
2021
Q1
$240K Buy
+1,100
New +$275K 0.06% 409
2019
Q4
Sell
-2,100
Closed -$302K 697
2019
Q3
$302K Sell
2,100
-1,782
-46% -$266K 0.06% 362
2019
Q2
$532K Buy
3,882
+1,403
+57% +$189K 0.11% 249
2019
Q1
$304K Buy
+2,479
New +$279K 0.06% 386
2017
Q4
Sell
-2,991
Closed -$243K 662
2017
Q3
$243K Buy
+2,991
New +$232K 0.06% 400

Other funds holding NICE

Bayesian Capital Management's NICE Position: Q2 2024 in Review

Bayesian Capital Management sold out of Nice (NICE) in Q2 2024, closing a stake of 7,465 shares — an estimated $1.95M sold.

Bayesian Capital Management first reported a position in NICE in Q3 2017 and held it in 9 quarters. The position peaked at $1.95M in Q1 2024. 405 funds tracked by Wall St. Rank hold NICE as of Q2 2024.

  • Bayesian Capital Management reported no remaining Nice position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 7,465 Nice shares in Q2 2024, an estimated $1.95M.
  • Bayesian Capital Management first reported a position in Nice in Q3 2017 and held it in 9 quarters.
  • Bayesian Capital Management's Nice position peaked at $1.95M in Q1 2024.
  • 405 funds tracked by Wall St. Rank held Nice as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.